#Moderna flu vaccine FDA

Total 1 articles

Moderna Shares Tumble as FDA Rejects Flu Vaccine Review

Moderna stock fell 8% after FDA declined to review its flu vaccine application, highlighting challenges in expanding beyond COVID-19 vaccines into competitive markets.

Feb 11, 2026